209 related articles for article (PubMed ID: 26478005)
1. Emerging role of P2X7 receptors in CNS health and disease.
Tewari M; Seth P
Ageing Res Rev; 2015 Nov; 24(Pt B):328-42. PubMed ID: 26478005
[TBL] [Abstract][Full Text] [Related]
2. P2X7 receptor: an emerging target in central nervous system diseases.
Sperlágh B; Illes P
Trends Pharmacol Sci; 2014 Oct; 35(10):537-47. PubMed ID: 25223574
[TBL] [Abstract][Full Text] [Related]
3. P2X7 Receptors Amplify CNS Damage in Neurodegenerative Diseases.
Illes P
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825423
[TBL] [Abstract][Full Text] [Related]
4. P2X7 receptors: channels, pores and more.
Volonté C; Apolloni S; Skaper SD; Burnstock G
CNS Neurol Disord Drug Targets; 2012 Sep; 11(6):705-21. PubMed ID: 22963440
[TBL] [Abstract][Full Text] [Related]
5. The P2X7 receptor: A main player in inflammation.
Adinolfi E; Giuliani AL; De Marchi E; Pegoraro A; Orioli E; Di Virgilio F
Biochem Pharmacol; 2018 May; 151():234-244. PubMed ID: 29288626
[TBL] [Abstract][Full Text] [Related]
6. P2X7 receptor antagonists: a patent review (2010-2015).
Park JH; Kim YC
Expert Opin Ther Pat; 2017 Mar; 27(3):257-267. PubMed ID: 27724045
[TBL] [Abstract][Full Text] [Related]
7. P2X7 Receptor: an Emerging Target in Alzheimer's Disease.
Huang Q; Ying J; Yu W; Dong Y; Xiong H; Zhang Y; Liu J; Wang X; Hua F
Mol Neurobiol; 2024 May; 61(5):2866-2880. PubMed ID: 37940779
[TBL] [Abstract][Full Text] [Related]
8. A current review on P2X7 receptor antagonist patents in the treatment of neuroinflammatory disorders: a patent review on antagonists.
Soni S; Lukhey MS; Thawkar BS; Chintamaneni M; Kaur G; Joshi H; Ramniwas S; Tuli HS
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jul; 397(7):4643-4656. PubMed ID: 38349395
[TBL] [Abstract][Full Text] [Related]
9. Role and therapeutic targets of P2X7 receptors in neurodegenerative diseases.
Zheng H; Liu Q; Zhou S; Luo H; Zhang W
Front Immunol; 2024; 15():1345625. PubMed ID: 38370420
[TBL] [Abstract][Full Text] [Related]
10. P2X7 Receptor Signaling in Stress and Depression.
Ribeiro DE; Roncalho AL; Glaser T; Ulrich H; Wegener G; Joca S
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31174279
[TBL] [Abstract][Full Text] [Related]
11. P2X7 receptors in the central nervous system.
Miras-Portugal MT; Ortega F; Gómez-Villafuertes R; Gualix J; Pérez-Sen R; Delicado EG
Biochem Pharmacol; 2021 May; 187():114472. PubMed ID: 33587917
[TBL] [Abstract][Full Text] [Related]
12. Astrocytes mediate HIV-1 Tat-induced neuronal damage via ligand-gated ion channel P2X7R.
Tewari M; Monika ; Varghse RK; Menon M; Seth P
J Neurochem; 2015 Feb; 132(4):464-76. PubMed ID: 25272052
[TBL] [Abstract][Full Text] [Related]
13. The purinergic P2X7 receptor as a potential drug target to combat neuroinflammation in neurodegenerative diseases.
Calzaferri F; Ruiz-Ruiz C; de Diego AMG; de Pascual R; Méndez-López I; Cano-Abad MF; Maneu V; de Los Ríos C; Gandía L; García AG
Med Res Rev; 2020 Nov; 40(6):2427-2465. PubMed ID: 32677086
[TBL] [Abstract][Full Text] [Related]
14. The evolution of P2X7 antagonists with a focus on CNS indications.
Rech JC; Bhattacharya A; Letavic MA; Savall BM
Bioorg Med Chem Lett; 2016 Aug; 26(16):3838-45. PubMed ID: 27426304
[TBL] [Abstract][Full Text] [Related]
15. Regulation of P2X7 receptor expression and function in the brain.
Jimenez-Mateos EM; Smith J; Nicke A; Engel T
Brain Res Bull; 2019 Sep; 151():153-163. PubMed ID: 30593878
[TBL] [Abstract][Full Text] [Related]
16. Purinergic P2X7 Receptor: A Cation Channel Sensitive to Tumor Microenvironment.
Scarpellino G; Genova T; Munaron L
Recent Pat Anticancer Drug Discov; 2019; 14(1):32-38. PubMed ID: 30652649
[TBL] [Abstract][Full Text] [Related]
17. Interactions of pannexin 1 with NMDA and P2X7 receptors in central nervous system pathologies: Possible role on chronic pain.
Bravo D; Maturana CJ; Pelissier T; Hernández A; Constandil L
Pharmacol Res; 2015 Nov; 101():86-93. PubMed ID: 26211949
[TBL] [Abstract][Full Text] [Related]
18. Involvement of microglial P2X7 receptor in pain modulation.
Zhang J; Gao L; Zhang Y; Wang H; Sun S; Wu LA
CNS Neurosci Ther; 2024 Jan; 30(1):e14496. PubMed ID: 37950524
[TBL] [Abstract][Full Text] [Related]
19. Beyond Seizure Control: Treating Comorbidities in Epilepsy via Targeting of the P2X7 Receptor.
Gil B; Smith J; Tang Y; Illes P; Engel T
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216493
[TBL] [Abstract][Full Text] [Related]
20. Role of P2X7 receptor-mediated IL-18/IL-18R signaling in morphine tolerance: multiple glial-neuronal dialogues in the rat spinal cord.
Chen ML; Cao H; Chu YX; Cheng LZ; Liang LL; Zhang YQ; Zhao ZQ
J Pain; 2012 Oct; 13(10):945-58. PubMed ID: 22968128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
